Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the SORAYA clinical-trial record, including its study details, eligibility criteria, locations, outcomes, publications, and documents, instead of a 403 Forbidden screen.
    Difference
    100%
    Check dated 2026-11-08T05:48:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T03:23:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces an NIH transition update stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T03:54:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2. The page continues to display a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-18T03:23:52.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T08:10:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the full study record, indicating restricted access; the page shows standard site chrome including a 403 message and a Revision notice.
    Difference
    19%
    Check dated 2026-09-20T02:07:08.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.